DexCom
DXCM
#879
Rank
A$39.48 B
Marketcap
A$100.69
Share price
-2.87%
Change (1 day)
-16.09%
Change (1 year)

Earnings for DexCom (DXCM)

Earnings in 2025 (TTM): A$1.51 Billion

According to DexCom's latest financial reports the company's current earnings are A$4.51 Billion. In 2024 the company made an earning of A$1.09 Billion a decrease over its 2023 earnings that were of A$1.09 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for DexCom from 2005 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) A$1.51 B38.48%
2024 A$1.09 B-0.37%
2023 A$1.09 B78.13%
2022 A$0.61 B47.34%
2021 A$0.41 B-10.11%
2020 A$0.46 B88.27%
2019 A$0.24 B-258.48%
2018 -A$0.16 Billion189.94%
2017 -A$53.84 Million-44.24%
2016 -A$96.55 Million12.43%
2015 -A$85.87 Million165.58%
2014 -A$32.34 Million-25.61%
2013 -A$43.46 Million-48.11%
2012 -A$83.76 Million24.5%
2011 -A$67.28 Million
2008 -A$79.45 Million13.18%
2007 -A$70.2 Million-5.36%
2006 -A$74.17 Million52.08%
2005 -A$48.77 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Edwards Lifesciences
EW
A$2.56 B 74.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Becton Dickinson
BDX
A$2.83 B 92.84%๐Ÿ‡บ๐Ÿ‡ธ USA
West Pharmaceutical
WST
A$0.90 B-38.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Tandem Diabetes Care
TNDM
-A$0.31 Billion-120.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Medtronic
MDT
A$9.62 B 554.40%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Abbott Laboratories
ABT
A$12.23 B 732.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
A$48.71 B 3,212.47%๐Ÿ‡บ๐Ÿ‡ธ USA
QuidelOrtho
QDEL
-A$1.71 Billion-216.18%๐Ÿ‡บ๐Ÿ‡ธ USA